Podcast
Questions and Answers
Which of the following is NOT a reason why individuals might seek additional hormone therapy beyond testosterone?
Which of the following is NOT a reason why individuals might seek additional hormone therapy beyond testosterone?
- To prevent pregnancy
- To increase testosterone levels (correct)
- To reduce or stop menstrual bleeding
- To reduce symptoms of dysphoria
What is the recommended medication for GAHT (Gender Affirming Hormone Therapy)?
What is the recommended medication for GAHT (Gender Affirming Hormone Therapy)?
- Antiandrogen therapy
- Testosterone
- Progesterone
- 17β-estradiol (correct)
Why might antiandrogen therapy be needed in addition to estrogen therapy?
Why might antiandrogen therapy be needed in addition to estrogen therapy?
- To increase testosterone levels
- To enhance the effects of estrogen (correct)
- To counteract the effects of estrogen
- To prevent pregnancy
What is the primary benefit of oral estradiol formulations?
What is the primary benefit of oral estradiol formulations?
Which of these statements is TRUE regarding hormonal contraceptives and gender affirmation?
Which of these statements is TRUE regarding hormonal contraceptives and gender affirmation?
What is the main reason why estrogen therapy might not be sufficient for some individuals?
What is the main reason why estrogen therapy might not be sufficient for some individuals?
Which of the following is NOT a factor considered when choosing a method of estrogen administration?
Which of the following is NOT a factor considered when choosing a method of estrogen administration?
What is the primary advantage of oral estradiol formulations over other methods of administration?
What is the primary advantage of oral estradiol formulations over other methods of administration?
What is the primary focus of the literature reviewed by Dhejne et al. regarding gender dysphoria?
What is the primary focus of the literature reviewed by Dhejne et al. regarding gender dysphoria?
Which publication explores the behavioral health impacts of gender-affirming hormone use?
Which publication explores the behavioral health impacts of gender-affirming hormone use?
What significant outcome is discussed in the review by Defreyne et al. regarding gender affirming surgery?
What significant outcome is discussed in the review by Defreyne et al. regarding gender affirming surgery?
What was a major finding reported in the 2015 U.S. Transgender Survey?
What was a major finding reported in the 2015 U.S. Transgender Survey?
Which organization developed the standards of care for transsexual, transgender, and gender-nonconforming individuals?
Which organization developed the standards of care for transsexual, transgender, and gender-nonconforming individuals?
Which of the following factors did Witcomb et al. focus on concerning transgender individuals?
Which of the following factors did Witcomb et al. focus on concerning transgender individuals?
What aspect of healthcare costs is evaluated by Defreyne et al. in relation to gender affirming surgery?
What aspect of healthcare costs is evaluated by Defreyne et al. in relation to gender affirming surgery?
What is the primary concern discussed in the literature by Dhejne and colleagues regarding mental health?
What is the primary concern discussed in the literature by Dhejne and colleagues regarding mental health?
Which of the following criteria is NOT specifically mentioned as a requirement for hormone therapy assessment according to WPATH?
Which of the following criteria is NOT specifically mentioned as a requirement for hormone therapy assessment according to WPATH?
What should be considered when assessing the appropriateness of hormone therapy for individuals with co-occurring medical or mental health conditions?
What should be considered when assessing the appropriateness of hormone therapy for individuals with co-occurring medical or mental health conditions?
What is the primary recommendation for individuals with co-occurring medical or mental health conditions who are seeking hormone therapy?
What is the primary recommendation for individuals with co-occurring medical or mental health conditions who are seeking hormone therapy?
What is the primary goal of the assessment process for hormone therapy, as stated in the text?
What is the primary goal of the assessment process for hormone therapy, as stated in the text?
What is the potential consequence of denying hormone therapy to individuals with gender dysphoria, according to the text?
What is the potential consequence of denying hormone therapy to individuals with gender dysphoria, according to the text?
What does the text suggest about the role of the individual's sense of self and agency in the assessment process?
What does the text suggest about the role of the individual's sense of self and agency in the assessment process?
Which of the following is NOT a factor that should be considered during the assessment process for hormone therapy, according to the text?
Which of the following is NOT a factor that should be considered during the assessment process for hormone therapy, according to the text?
What does the text suggest about the decision to deny or delay hormone therapy?
What does the text suggest about the decision to deny or delay hormone therapy?
Study Notes
Gender-Affirming Hormone Therapy
- Gender-affirming hormone therapy is used to treat transgender individuals, aiming to align their physical body with their gender identity.
Mental Health and Gender Dysphoria
- Gender dysphoria is associated with higher levels of depression, anxiety, and suicidality.
- A review of literature found that mental health issues are prevalent in transgender individuals, highlighting the need for comprehensive care.
Healthcare Costs and Quality of Life
- Gender-affirming surgery in trans men is associated with improved quality of life outcomes and reduced healthcare costs.
Hormone Therapy Options
- Estrogen and antiandrogen therapy are used to suppress testosterone and its effects.
- 17β-estradiol (estradiol) is the recommended medication for gender-affirming hormone therapy, with a low risk profile and high effectiveness.
- Oral estradiol formulation is dosed daily, providing steady levels of estrogen in the body, and is relatively cheap, accessible, and easy to administer.
Assessment Criteria for Hormone Therapy
- WPATH recommends considering four criteria during assessment, including:
- Persistent, well-documented gender dysphoria (of at least 6 months).
- Capacity to make a fully informed decision and consent to treatment.
- Age of majority in a given country.
- Reasonable control of significant medical or mental health concerns.
Important Considerations
- The presence of co-occurring medical or mental health conditions should not necessarily contraindicate or delay access to hormone therapy.
- Denial of hormone therapy can worsen depression, anxiety, and suicidality, and should not be taken lightly.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz covers hormone therapy for adults with gender dysphoria, including its effects on mental health.
